PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

This project is part of the EDCTP2 Programme supported by the European Union.
EDCTP
EU

Search

Search

  • About us
    • What we do
    • Governance
    • PAMAfrica scientists
    • PAMAfrica students
  • Work packages
    • Next-generation drug combination for uncomplicated malaria
    • First malaria treatment for babies under 5kg
    • New medicine for treatement of severe malaria
    • Building research capacity
  • Consortium partners
  • Newsroom
    • Resources
    • News
Search
HomeNewsroomNews

News

1

A warm PAMAfrica welcome to Merck as it joins the consortium

Merck joining forces with the consortium represents a major achievement

04 Oct 2022

2nd Annual PAMAfrica Consortium Meeting

25 Aug 2022

1st Annual PAMAfrica Consortium Meeting

13 Oct 2021

Interview with Alberto Chauque - One of PAMAfrica’s MSc students

11 Jun 2021

Interview with Victor Asua - One of PAMAfrica’s PhD students

19 May 2021

Interview with Dr Jean Wendepouiré Sawadogo, second PAMAfrica MSc student

25 Feb 2021

Interview with Fabrice Mougeni - First PAMAfrica MSc student

02 Dec 2020

Dr Halidou Tinto elected Fellow of the African Academy of Sciences

31 Aug 2020
photo: ISGlobal

EDCTP interview with Dr Tim Wells

EDCTP e-magazine talked to Dr Tim Wells, Chief Scientific Officer of Medicines for Malaria Venture (MMV). He highlighted the important elements of the EDCTP-funded PAMAfrica project.

01 Jul 2020

International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa

03 Mar 2020

Contact us

infopamafrica [at] mmv [dot] org

A Remora website by Manta Ray Media